Novavax (NVAX) Tax Provisions (2010 - 2026)
Novavax (NVAX) posted quarterly Tax Provisions of $985000.0 for Q1 2026, down 17.92% year-over-year from $1.2 million in Q1 2025, and up 161.97% quarter-over-quarter from $376000.0 in Q4 2025.
Novavax (NVAX) Tax Provisions (2010 - 2026) Analysis & Trends
Novavax's Tax Provisions history runs 9 years deep, the most recent figure standing at $985000.0 for Q1 2026.
- In Q1 2026, Tax Provisions fell 17.92% year-over-year to $985000.0; the TTM figure through Mar 2026 stood at $1.6 million (down 83.2% YoY), while the FY2025 annual figure was $1.9 million, down 82.86% from the prior year.
- Tax Provisions for Q1 2026 stood at $985000.0, up from $376000.0 in the prior quarter.
- The five-year high for Tax Provisions was $7.4 million in Q4 2024, with the low at -$2.3 million in Q4 2022.
- The 5-year median for Tax Provisions is $1.2 million (2023), against an average of $1.2 million.
- The sharpest annual moves came in 2023 and 2024: Tax Provisions plunged 128.2% in 2023, then surged 1641.96% in 2024.
- Novavax's Tax Provisions stood at -$2.3 million in 2022, then surged by 174.69% to $1.7 million in 2023, then jumped by 341.29% to $7.4 million in 2024, then tumbled by 94.95% to $376000.0 in 2025, then surged by 161.97% to $985000.0 in 2026.
- Business Quant data shows NVAX's Tax Provisions at $985000.0 in Q1 2026, $376000.0 in Q4 2025, and -$657000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Novavax | 1.33 Bn | 607.37 Mn | 42.45 Mn | 1.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.71 Mn |
| Mar 31, 2026 | 985,000.00 |
| Dec 31, 2025 | 376,000.00 |
| Sep 30, 2025 | -657,000.00 |
| Jun 30, 2025 | 946,000.00 |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 7.45 Mn |
| Sep 30, 2024 | -1.03 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Mar 31, 2024 | 2.26 Mn |
| Dec 31, 2023 | 1.69 Mn |
| Sep 30, 2023 | -697,000.00 |
| Jun 30, 2023 | -143,000.00 |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | -2.26 Mn |
| Sep 30, 2022 | 2.47 Mn |
| Jun 30, 2022 | 1.42 Mn |
| Mar 31, 2022 | 2.66 Mn |
| Dec 31, 2021 | 16.61 Mn |
| Sep 30, 2021 | 6.04 Mn |